SUPN

Supernus Pharmaceuticals INC

+$166.1M

Net Activity

Institutions Holding

328

Popularity Rank

#1815

Avg Weight

0.10%

Total Value

$3.0B

Ownership Trend

328 institutions currently hold SUPN, with 154 net buyers and 159 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

159

Net Buying Institutions

154

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$454.7M
MM
Millennium Management LLC
$171.4M
VP
Vanguard Portfolio Management LLC
$167.4M
VC
Vanguard Capital Management LLC
$127.5M
DF
Dimensional Fund Advisors LP
$119.2M

Top 5 by Conviction

KA
Krensavage Asset Management, LLC
5.67%
AC
Ashford Capital Management INC
4.12%
SI
Sofinnova Investments, Inc.
1.87%
AC
Armistice Capital, LLC
1.74%
RH
Rice Hall James & Associates, LLC
1.37%
View all 328 holding institutions

Quarterly Activity

Recent Activity

+$1.6B

Total Buy Value

$1.3B

Total Sell Value

New buy37
Trim117
Add117
Sold out42

154

Net Buyers

159

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding SUPERNUS PHARMACEUTICALS INC (SUPN)?
Major stakeholders currently include BlackRock, Inc. ($454.7M), Millennium Management LLC ($171.4M), Vanguard Portfolio Management LLC ($167.4M). Based on the latest 13F filings, there are a total of 328 tracked investment funds and institutions maintaining positions in SUPN.
What is the overall institutional sentiment toward SUPN recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $166.1M, driven by 154 managers accumulating shares while 159 reduced their exposure.
Which institutions have been selling or reducing their SUPN positions?
In the latest period, 117 funds trimmed their holdings, and 42 managers completely exited their positions. The aggregate reported sell value was $1.3B.
Are there any notable investors adding SUPN to their portfolios?
Yes, buying activity remains notable. 37 institutions opened new positions in {ticker}, and 117 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.6B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

288 institutions currently hold both SUPN and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

292 institutions currently hold both SUPN and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

291 institutions currently hold both SUPN and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail